"I am the Way, the Truth, and the Life"

Father God, thank you for the love of the truth you have given me. Please bless me with the wisdom, knowledge and discernment needed to always present the truth in an attitude of grace and love. Use this blog and Northwoods Ministries for your glory. Help us all to read and to study Your Word without preconceived notions, but rather, let scripture interpret scripture in the presence of the Holy Spirit. All praise to our Lord and Saviour Jesus Christ.

Please note: All my writings and comments appear in bold italics in this colour
Showing posts with label studies. Show all posts
Showing posts with label studies. Show all posts

Sunday, April 26, 2026

Marijuana science > Scans reveal some of what weed really does in your brain, but science still misses the most important aspect

 

What weed really does to your brain, according to hundreds of thousands of scans




Marijana has been known to take a toll on the body.

It can irritate the lungs, damage blood vessels and accelerate heart rate. Not to mention the scromiting, the screaming — and vomiting! — that can accompany long-term, heavy use.

The brain also takes some hits.

Over 52 million Americans are believed to smoke pot, which may be harming certain areas of their brain.
Jared Larson / NY Post

“From a brain imaging perspective, marijuana use is consistently associated with measurable changes in brain function,” Dr. Daniel Amen, founder of Amen Clinics, which has conducted hundreds of thousands of scans to measure blood flow and activity in patient brains, told The Post.

A study last year out of the University of Colorado, for example, linked chronic use to a decline in working memory, the brain’s ability to retain, process and use information immediately.

The other ways marijuana can drain your brain may blow your mind. Here’s a look at six of the potential puff-ects.

Coordination

The CDC estimates that 52.5 million Americans, or about 19% of the US population 12 and older, get high at least once a year. The legalization of cannabis in many states has increased access to grass, putting the ole noggin in the crosshairs.

“Marijuana users demonstrate widespread reductions in cerebral blood flow, particularly in regions critical for memory, coordination, emotion and executive function,” Amen said.

The main psychoactive compound of marijuana, THC, is the culprit here. It disrupts the brain’s cerebellum and basal ganglia, which are responsible for motor control, balance and coordination.

That could manifest as lane weaving while driving, body swaying due to instability and delayed reactions. These effects are most pronounced in the first hour after marijuana use and can last several hours.

Research continues into the long-term effects of frequent marijuana use and brain function.

Memory

THC also binds to receptors in the hippocampus, which plays a critical role in memory formation. It’s one of the brain regions most affected by weed, Amen noted.

“Cannabis users show significant hippocampal hypoperfusion, with studies demonstrating reductions of up to 13–17% compared to controls,” Amen said, referring to the sustained blood flow reduction to the hippocampus.

“This is clinically meaningful because the hippocampus is highly vulnerable to neurodegenerative processes and is essential for learning and memory consolidation,” he added.

In short, marijuana can disrupt the process of turning short-term memories into long-lasting ones.

Judgment

“The prefrontal cortex, responsible for judgment, impulse control and decision-making, shows reduced activation as well,” Amen said.

This can fuel smokers to seek out immediate rewards while overlooking long-term consequences, undermining their ability to assess risk and adapt to new information.

Cannabis can significantly affect mental health, increasing the risk of schizophrenia, psychosis and addiction.
AndreaMonica – stock.adobe.com

Attention

Marijuana brings the smoke — and the brain fog.

Hash can make it harder to plan, organize, concentrate and multitask. Blame THC’s effect on the prefrontal cortex.

Sensory perception

Cannabis can intensify taste, sound, smell, vision and touch, making music feel more immersive and colors more vibrant, because THC activates brain regions linked to sensory processing.

On the flip side, marijuana can also dull night vision and slow glare recovery, making nighttime driving trickier.

Mental health

“The amygdala, which regulates emotional processing, demonstrates decreased activity in imaging studies,” Amen said.

“This may contribute to emotional blunting in some individuals, but cannabis use is also associated with increased rates of anxiety, paranoia and psychosis, particularly in high-frequency users or those with genetic vulnerability,” he noted.

Research shows that users are also at increased risk of mood changes, panic attacks, depression, addiction, schizophrenia and suicidal ideation.

Some of these brain changes may ease upon quitting marijuana. Research into the long-term effects of frequent use and neural recovery is ongoing.

“Findings suggest that marijuana use is associated with global reductions in brain function, rather than enhancement,” Amen said.

“While some individuals report short-term benefits, imaging data indicate potential negative effects on memory, coordination, emotional regulation and executive function — especially with chronic or heavy use.”

Science still hasn't figured out what I have been observing for 50 years:

Marijuana use stops the maturing process in most users

Because of this, marijuana is responsible for the dramatic drop in the birth rates in western societies - youth tend to remain in their teens emotionally right through their twenties and thirties as long as they continue using.

Emotionally immature youth don't want to raise children. 

Playing Russian Roulette with Your Sanity



Saturday, January 3, 2026

Stanford study > At least 20,000 deaths from Covid Vax

 

Stanford led study: at least 20,000 global deaths from COVID jabs


New COVID Vax Paper Breaks with the Narrative

By trialsitenews , republished by permission

TrialSite Staff | Making Biomedical Research Evidence Accessible to All

Malone News is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Dec. 23, 2025, 5:30 a.m.

In a high-profile analysis published in JAMA Health Forum, a team from Stanford University, Università Cattolica del Sacro Cuore and the Fondazione Policlinico Universitario A. Gemelli IRCCS led by John P. A. Ioannidis set out to answer one of the most contested questions of the pandemic era: How many lives did COVID-19 vaccination actually save worldwide? The study estimates that COVID-19 vaccination averted approximately 2.5 million deaths globally between 2020 and 2024, with a wide uncertainty range of 1.4 to 4.0 million, and saved about 15 million life-years, though results depend heavily on modeling assumptions. Nearly 90% of deaths averted occurred in adults aged 60 years and older, while children, adolescents, and young adults contributed a negligible share of the total benefit. Compared with earlier pandemic models, these findings suggest a far more limited, age-concentrated mortality benefit, particularly during the Omicron period and among those vaccinated before first infection.

A Quiet but Explosive Admission

Dr. Ioannidis and colleagues make an unusually candid concession for a high-profile vaccine-benefit paper: they do not separate deaths averted by vaccine effectiveness from deaths caused by vaccine-related harms. In fact they explicitly acknowledge that randomized trial data are insufficient to quantify vaccine-associated mortality and that estimates derived from registries and observational sources carry “substantial uncertainty.”

This is not a minor caveat—it is a structural limitation of the analysis. The authors further note that, depending on ethical framing and risk aversion, a death caused by an intervention may not be considered equivalent to a death averted by it, particularly when harms cluster in specific subpopulations.

To put bounds around this uncertainty, the authors turn to eAppendix 2 (Supplement 1), where they restrict analysis to widely recognized and accepted fatal adverse events: thrombosis with thrombocytopenia after adenovirus-vector vaccines, myocarditis following mRNA vaccines (primarily in younger males), and deaths temporally associated with vaccination in highly debilitated nursing-home residents.

Using global administration data (~13.64 billion doses) and conservative risk assumptions, they estimate roughly 20,000 vaccine-associated deaths worldwide, while an independent extrapolation from Qatar’s national mortality review suggests a broader range of approximately 16,000 to 48,000 deaths.

Compared with the study’s central estimate of ~2.5 million lives saved, this supports the authors’ statement that vaccine-related deaths were “probably” about two orders of magnitude lower than benefits at the population level.

The critical word is “probably.” The authors explicitly state that these adverse-event death estimates carry “very large uncertainty” and emphasize that the margin between benefit and harm may be substantially smaller—or even reversed—in specific subgroups where risks are concentrated and benefits are limited, such as younger males or frail elderly residents.

In effect, the paper concedes that while COVID-19 vaccination likely reduced mortality overall, net benefit was neither uniform nor guaranteed across populations. A bombshell acknowledgment—confined to the supplement rather than the abstract—directly challenges any absolutist claim that vaccine harms were negligible or irrelevant and represents a rare moment of methodological and ethical candor in the COVID-19 vaccine literature.

Please continue reading on Dr Malone's substack at:

What the Study Did—and Did Not—Do


=============================================================================================